======= ZNF292 =======
== Gene Information ==
* **Official Symbol**: ZNF292
* **Official Name**: zinc finger protein 292
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23036|23036]]
* **UniProt**: [[https://www.uniprot.org/uniprot/O60281|O60281]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=ZNF292&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ZNF292|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/616213|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a growth hormone-dependent, zinc finger transcription factor that functions as a tumor suppressor. Naturally occurring mutations in this gene are associated with gastric cancer, colorectal cancer, and chronic lymphocytic leukemia. [provided by RefSeq, May 2017].
* **UniProt Summary**: May be involved in transcriptional regulation.
No Pfam Domain information is available for this gene.
|DNA-binding transcription activator activity, RNA polymerase II-specific|
|positive regulation of transcription by RNA polymerase II|
|DNA binding|
|positive regulation of transcription, DNA-templated|
|DNA-binding transcription factor activity, RNA polymerase II-specific|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|positive regulation of RNA metabolic process|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|positive regulation of gene expression|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp502|Milciclib 2μM R08 exp502]]|-2.58|
|[[:results:exp514|Phorbol-12-myristate-13-acetate 0.57μM R08 exp514]]|-2.58|
|[[:results:exp532|TIC10 10μM R08 exp532]]|-2.52|
|[[:results:exp460|BML-284 0.09μM R08 exp460]]|-2.28|
|[[:results:exp106|UM131593 0.2μM R03 exp106]]|-2.23|
|[[:results:exp435|JQ1 0.8μM R08 exp435]]|-2.2|
|[[:results:exp59|UMK57 1μM R01 exp59]]|-2|
|[[:results:exp440|Aphidicolin 0.4μM R08 exp440]]|-1.93|
|[[:results:exp441|GSK-J4 1.5μM R08 exp441]]|-1.85|
|[[:results:exp466|Cannabidiol 20μM R08 exp466]]|-1.82|
|[[:results:exp312|2-Methoxyestradiol 0.55 to 1μM on day4 R07 exp312]]|-1.78|
|[[:results:exp191|Hypoxia 5%O2 R04 exp191]]|1.79|
|[[:results:exp293|Myriocin 25μM R06 exp293]]|1.88|
|[[:results:exp504|MK2206 4μM R08 exp504]]|1.92|
|[[:results:exp300|VE-822 0.04μM R06 exp300]]|2.16|
|[[:results:exp352|Dexamethasone 0.006 to 0.015μM on day4 R07 exp352]]|3.17|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 19036
* **Expression level (log2 read counts)**: 6.89
{{:chemogenomics:nalm6 dist.png?nolink |}}